Edition:
India

Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

25,975.01ZAc
18 May 2018
Change (% chg)

-32.99 (-0.13%)
Prev Close
26,008.00
Open
26,000.00
Day's High
26,400.00
Day's Low
25,635.00
Volume
784,265
Avg. Vol
1,611,134
52-wk High
32,750.00
52-wk Low
22,987.00

Chart for

About

Aspen Pharmacare Holdings Limited is a South Africa-based supplier and manufacturer of branded and generic pharmaceutical products, as well as infant nutritional and consumer healthcare products. The Company's segments include International, South Africa, Asia Pacific and Sub-Saharan Africa (SSA). Its International business... (more)

Overall

Beta: 0.56
Market Cap(Mil.): R139,674.20
Shares Outstanding(Mil.): 456.45
Dividend: 287.00
Yield (%): 0.94

Financials

  APNJ.J Industry Sector
P/E (TTM): 27.38 30.95 32.75
EPS (TTM): 11.17 -- --
ROI: 6.19 14.84 14.38
ROE: 11.92 16.34 16.07

South African drugmaker Aspen secures 3.4 billion euro credit line

JOHANNESBURG, May 17 Aspen Pharmacare, Africa's biggest generic drugmaker, said on Thursday it had secured a 3.4 billion euro ($4 billion) credit facility for refinancing debt at three of its subsidiaries.

17 May 2018

Aspen expands revenue-boosting therapeutic unit with new $80 million plant

PORT ELIZABETH, South Africa South African drug maker Aspen Pharmacare will produce up to 3.6 billion pills a year at its new manufacturing plant as it expands its therapeutic portfolio, Chief Executive Stephen Saad said on Monday at the official launch.

07 May 2018

Aspen expands revenue-boosting therapeutic unit with new $80 million plant

PORT ELIZABETH, South Africa, May 7 South African drug maker Aspen Pharmacare will produce up to 3.6 billion pills a year at its new manufacturing plant as it expands its therapeutic portfolio, Chief Executive Stephen Saad said on Monday at the official launch.

07 May 2018

Aspen Pharmacare eyes Saudi Arabia to expand infant milk business

JOHANNESBURG, March 8 South Africa's Aspen Pharmacare is looking to expand its infant milk formula business into Saudi Arabia, its deputy Chief Executive said on Thursday, as the pharmaceutical company seeks to grow its brand presence in the Middle-East.

08 Mar 2018

Therapeutic brands help lift Aspen Pharmacare's H1 profit

JOHANNESBURG, March 8 South Africa's Aspen Pharmacare said on Thursday first-half earnings rose 26 percent, buoyed by a strong result from therapeutic focused brands.

08 Mar 2018

BRIEF-Aspen Pharmacare Says HY ‍Normalised HEPS Increased By 26 Pct

* ‍NORMALISED HEADLINE EARNINGS PER SHARE INCREASED BY 26% TO 872 CENTS FOR SIX MONTHS ENDED 31 DECEMBER 2017​

08 Mar 2018

BRIEF-Aspen Expects HY HEPS Between 820.4 To 846.0 Cents Per Share​

* EXPECTS HY HEADLINE EARNINGS PER TO IMPROVE 28% TO 32% BETWEEN 820.4 TO 846.0 CENTS PER SHARE​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

15 Feb 2018

South Africa's Aspen to start review of infant milk formula unit

JOHANNESBURG, Jan 29 Aspen Pharmacare will review its infant milk formula business with options including a sale to a strategic partner, Africa's biggest generic drugmaker said on Monday.

29 Jan 2018

BRIEF-Aspen Says To Review Global Nutritionals Business

* ‍HAS BEEN EXPLORING OPTIONS TO ENHANCE VALUE OF ITS GLOBAL NUTRITIONALS BUSINESS ("NUTRITIONALS") SINCE RECEIVING AN UNSOLICITED APPROACH IN Q3 OF LAST YEAR​

29 Jan 2018

Drugmaker GSK cuts back in Africa to hone emerging markets model

LONDON, Jan 17 GlaxoSmithKline is cutting back operations in Africa as its new Chief Executive Emma Walmsley seeks to make the British drugmaker more competitive in emerging markets by ditching her predecessor's expansion plans for the continent.

17 Jan 2018

Earnings vs. Estimates